help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2007
Endocrinology, doi:10.1210/en.2007-0006
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
148/12/6134    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, J.-Y.
Right arrow Articles by Kim, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, J.-Y.
Right arrow Articles by Kim, J.-M.

Submitted on January 3, 2007
Accepted on September 12, 2007

Cellular defense mechanisms against benzo[a]pyrene in testicular Leydig cells: 1 Implications of p53, aryl-hydrocarbon receptor and cytochrome P450 1A1 status

Jin-Yong Chung, Ji Young Kim, Yoon Jae Kim, Sun Ju Jung, Ji-Eun Park, Seung Gee Lee, Jin Tac Kim, Seunghoon Oh, Chang Joo Lee, Yong-Dal Yoon, Young Hyun Yoo, and Jong-Min Kim*

Department of Anatomy and Cell Biology, College of Medicine, Dong-A University, Busan 602–714, Korea; Department of Physiology, College of Medicine, Dankook University, Cheonan 330–714, Korea; Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 133–791, Korea

* To whom correspondence should be addressed. E-mail: jmkim7{at}dau.ac.kr.

Leydig cells of the mammalian testis produce testosterone and support spermatogenesis, and thereby their role in male function is fundamental. Although benzo[a]pyrene (B[a]P) has been known to exhibit carcinogenic, apoptogenic, and endocrine disrupting activities, its potential signaling system in Leydig cells remain to be discovered. In the present study, using the TM3 Leydig cell line and primary Leydig cells, we showed that Leydig cells do not die by exposure to B[a]P, and found that an increased level of XIAP may be associated with the anti-apoptotic process. The Leydig cells were shown to express p53 but its translational level was extremely low. Although a high level of p53 protein was not necessary for BPDE (a final B[a]P metabolite)-induced apoptosis in Leydig cells, the apoptosis of primary Leydig cells appears to be p53-independent. This indicates the lack of p53 function in primary Leydig cells. Furthermore, Leydig cells were found to retain insignificant levels of endogenous AhR and Arnt proteins in nature. Exposure to B[a]P did not result in a significant increase in AhR proteins that are required for CYP1A1 transcription. CYP1A1 expression was present in Leydig cells but at levels insufficient to exhibit its activity. Finally, we have demonstrated that overexpression of CYP1A1 in Leydig cells sensitizes the cells to exhibit its activity in the presence of B[a]P, and thus induction of apoptosis. Together, these results indicate that the deficiency of CYP1A1 activity might be a decisive condition rendering Leydig cells secure from exogenous PAHs like B[a]P.


Key words: Benzo[a]pyrene • cytoprotection • apoptosis • Leydig cells • Testis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society